93 5127
Pill imprint 93 5127 has been identified as Benazepril hydrochloride 40 mg.
Benazepril is used in the treatment of high blood pressure; diabetic kidney disease; heart failure; left ventricular dysfunction and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy.
Benazepril 40 mg is not subject to the Controlled Substances Act.
See also related documents.
Benazepril hydrochloride Images
- Imprint:
-
93
5127 - Strength:
- 40 mg
- Color:
- Pink
- Size:
- 8.00 mm
- Shape:
- Three-sided
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide colloidal
crospovidone
hypromellose
ferric oxide yellow
lactose monohydrate
magnesium stearate
microcrystalline cellulose
polyethylene glycol
povidone
corn starch
titanium dioxide
triacetin
ferric oxide red
- Drug Class:
- Angiotensin converting enzyme inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- 00093-5127
| NDC Code | Manufacturer / Repackager |
|---|---|
| 68258-1055 | Dispensing Solutions Inc. (repackager) |
| 66336-0124 | Dispensing Solutions Inc. (repackager) |
Note: Inactive ingredients may vary.
More Benazepril Hydrochloride resources
- Benazepril (Wolters Kluwer)
- benazepril (Cerner Multum)
- benazepril (Micromedex) - Includes Dosage Information
- Benazepril Hydrochloride (AHFS DI)
- Benazepril (FDA)
- Benazepril Hydrochloride (Wolters Kluwer)


